Skip to main content

Table 2 Comparison of the kappa values, sensitivities and specificities obtained between the HC2 (gold standard) and the PCR-based techniques

From: Assessment of a new low-cost, PCR-based strategy for high-risk human papillomavirus DNA detection for cervical cancer prevention

PCR technique

Kappa value (CI 95%)

Sensitivity (CI 95%)

Specificity (CI 95%)

GP-EIA

0.71 (0.63–0.78)

70,4% (62,1 – 78,7)

96,2% (94,3 – 98,1)

BSGP-EIA

0.78 (0.71–0.84)

77,4% (69,7 – 85,1)

96,9% (95,3 – 98,5)

pU

0.63 (0.55–0.72)

60,9% (52,0 – 69,8)

96,5% (94,6 – 98,3)

BSGP-EIA + pU

0.82 (0.76–0.88)

88,7% (82,8 – 94,6)

95,1% (93,1 – 97,1)